SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,000 | -10.1% | 39,165 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $1,007,000 | +20.3% | 38,401 | +18.0% | 0.00% | 0.0% |
| Q1 2023 | $837,000 | -2.2% | 32,535 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $856,000 | +7681.8% | 32,928 | +24111.8% | 0.00% | – |
| Q3 2022 | $11,000 | +22.2% | 136 | -64.7% | 0.00% | – |
| Q2 2022 | $9,000 | -59.1% | 385 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -8.3% | 385 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | 0.0% | 385 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -25.0% | 385 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +14.3% | 385 | 0.0% | 0.00% | – |
| Q1 2021 | $28,000 | -22.2% | 385 | -23.5% | 0.00% | – |
| Q4 2020 | $36,000 | +50.0% | 503 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | +14.3% | 503 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |